P2X receptor-stimulated calcium responses in preglomerular vascular smooth muscle cells involves 20-hydroxyeicosatetraenoic acid

Journal of Pharmacology and Experimental Therapeutics

Volumn 311, Issue 3, 2004, Pages 1211-1217

  Zhao, Xueying ^a   Falck, John R ^b   Gopal, V Raj ^b   Inscho, Edward W ^a   Imig, John D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

20 HYDROXYEICOSA 6,15 DIENOIC ACID; 20 HYDROXYICOSATETRAENOIC ACID; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; CALCIUM; ENZYME INHIBITOR; FURA 2; N METHYLSUFONYL 12,12 DIBROMODODEC 11 ENAMIDE; PURINE P2X RECEPTOR; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL ISOLATION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; ENZYME INHIBITION; FLUORESCENCE MICROSCOPY; HEMODYNAMIC MONITORING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ADENOSINE TRIPHOSPHATE; AMIDES; ANIMALS; CALCIUM; CAPILLARIES; CELL SEPARATION; HYDROXYEICOSATETRAENOIC ACIDS; KIDNEY GLOMERULUS; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2; RENAL CIRCULATION; SPECTROMETRY, FLUORESCENCE; SULFONES;

EID: 10044255250     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.070797     Document Type: Article

References (40)

1. 2Y purinoceptors? Pharmacol Ther 64:445-475.
2. Alonso-Galicia M, Falck JR, Reddy KM, and Roman RJ (1999) 20-HETE agonists and antagonists in the renal circulation. Am J Physiol 277:F790-F796.
3. Arendshorst WJ and Navar LG (1993) Renal circulation and glomerular hemodynamics, in Diseases of the Kidney (Schrier RW and Gottschalk C eds) pp 65-117, Little, Brown and Company, Boston, MA.
4. Bell PD, Lapointe JY, Sabirov R, Hayashi S, Peti-Peterdi J, Manabe K, Kovacs G, and Okada Y (2003) Macula densa cell signaling involves ATP release through a maxi anion channel. Proc Natl Acad Sci USA 100:4322-4327.
5. Bolego C, Ceruti S, Brambilla R, Puglisi L, Cattabeni F, Burnstock G, and Abbracchio MP (1997) Characterization of the signalling pathways involved in ATP and basic fibroblast growth factor-induced astrogliosis. Br J Pharmacol 121:1692-1699.
6. Burnstock G (1978) A basis for distinguishing two types of purinergic receptor, in Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach (Bolis L and Straub RCO eds) pp 107-118, Raven Press Ltd., New York.
7. 1 purinoceptors by autoradiography and immunohistochemistry in rat kidneys. Am J Physiol 274:F799-F804.
8. 2+-mobilizing receptors for ATP and UTP. Cell Calcium 17:111-119.
9. Dubyak GR and el-Moatassim C (1993) Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol Cell Physiol 265:C577-C606.
10. el-Moatassim C, Dornand J, and Mani JC (1992) Extracellular ATP and cell signaling. Biochim Biophys Acta 1134:31-45.
11. Eltze M and Ullrich B (1996) Characterization of vascular P2 purinoceptors in the rat isolated perfused kidney. Eur J Pharmacol 306:139-152.
12. Evans RJ, Surprenant A, and North RA (1998) P2X receptors: Cloned and expressed, in The P2 Nucleotide Receptors (Turner JT, Weisman GA, and Fedan JS eds) pp 43-61, Humana Press, Inc., Totowa, NJ.
13. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, and Williams M (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156.
14. Fredholm BB, Abbracchio MP, Burnstock G, Dubyak GR, Harden TK, Jacobson KA, Schwabe U, and Williams M (1997) Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol Sci 18:79-82.
15. 2+ current. J Physiol (Lond) 507:771-781.
16. Harder DR, Gebremedhin D, Narayanan J, Jefcoat C, Falck JR, Campbell WB, and Roman RJ (1994) Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels. Am J Physiol Heart Circ Physiol 266:H2098-H2107.
17. Hercule HC and Oyekan AO (2000) Cytochrome P450 ω/ω-1 hydroxylase-derived eicosanoids contribute to endothelin (A) and endothelin (B) receptor-mediated vasoconstriction to endothelin-1 in the rat preglomerular arteriole. J Pharmacol Exp Ther 292:1153-1160.
18. Imig JD, Falck JR, and Inscho EW (1999) Contribution of cytochrome P450 epoxygenase and hydroxylase pathways to afferent arteriolar autoregulatory responsiveness. Br J Pharmacol 127:1399-1405.
19. Imig JD, Pham BT, LeBlanc EA, Reddy KM, Falck JR, and Inscho EW (2000) Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses. Hypertension 35:307-312.
20. Imig JD, Zou AP, Stec DE, Harder DR, Falck JR, and Roman RJ (1996) Formation and actions of 20-hydroxyeicosatertraenoic acid in rat renal arterioles. Am J Physiol Regul Integr Comp 270:R217-R227.
21. Inscho EW (2001) P2 receptors in regulation of renal microvascular function. Am J Physiol Renal Physiol 280:F927-F944.
22. Inscho EW and Cook AK (2002) P2 receptor-mediated afferent arteriolar vasoconstriction during calcium blockade. Am J Physiol Renal Physiol 282:F245-F255.
23. Inscho EW, Cook AK, Imig JD, Vial C, and Evans RJ (2003) Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior. J Clin Investig 112:1895-1905.
24. Inscho EW, Cook AK, Mui V, and Miller J (1998) Direct assessment of renal microvascular responses to P2-purinoceptor agonists. Am J Physiol Renal Physiol 274:F718-F727.
25. Inscho EW, Cook AK, and Navar LG (1996) Pressure-mediated vasoconstriction of juxtamedullary afferent arterioles involves P2-purinoceptor activation. Am J Physiol Renal Fluid Electrolyte Physiol 271:F1077-F1085.
26. Inscho EW, LeBlanc EA, Pham BT, White SM, and Imig JD (1999a) Purinoceptor-mediated calcium signaling in preglomerular smooth muscle cells. Hypertension 33:195-200.
27. Inscho EW, Ohishi K, Cook AK, Belott TP, and Navar LG (1995) Calcium activation mechanisms in the renal microvascular response to extracellular ATP. Am J Physiol Renal Fluid Electrolyte Physiol 268:F876-F884.
28. 2+ signaling in preglomerular smooth muscle cells. Am J Physiol Renal Physiol 276:F450-F456.
29. Lange A, Gebremedhin D, Narayanan J, and Harder D (1997) 20-hydroxyeicosatetraenoic acid-induced vasoconstriction and inhibition of potassium current in cerebral vascular smooth muscle is dependent on activation of protein kinase C. J Biol Chem 272:27345-27352.
30. Ma YH, Gebremedhin D, Schwartzman ML, Falck JR, Clark JE, Masters BS, Harder DR, and Roman RJ (1993) 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 72:126-136.
31. Maier KG and Roman RJ (2001) Cytochrome P450 metabolites of arachidonic acid in the control of renal function. Curr Opin Nephrol Hypertens 10:81-87.
32. Majid DS, Inscho EW, and Navar LG (1999) P2 purinoceptor saturation by adenosine triphosphate impairs renal autoregulation in dogs. J Am Soc Nephrol 10:492-498.
33. Mitchell KD and Navar LG (1993) Modulation of tubuloglomerular feedback responsiveness by extracellular ATP. Am J Physiol Renal Fluid Electrolyte Physiol 264:F458-F466.
34. Navar LG, Inscho EW, Majid SA, Imig JD, Harrison-Bernard LM, and Mitchell KD (1996) Paracrine regulation of the renal microcirculation. Physiol Rev 76:425-536.
35. Pfeilschifter J (1990) Extracellular ATP stimulates polyphosphoinositide hydrolysis and prostaglandin synthesis in rat renal mesangial cells. Involvement of a pertussis toxin-sensitive guanine nucleotide binding protein and feedback inhibition by protein kinase C. Cell Signal 2:129-138.
36. Ralevic V and Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492.
37. Schulze-Lohoff E, Zanner S, Ogilvie A, and Sterzel RB (1992) Extracellular ATP stimulates proliferation of cultured mesangial cells via P2-purinergic receptors. Am J Physiol Renal Fluid Electrolyte Physiol 263:F374-F383.
38. Wang MH, Brand-Schieber E, Zand BA, Nguyen X, Falck JR, Balu N, and Schwartzman ML (1998) Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors. J Pharmacol Exp Ther 284:966-973.
39. White SM, Imig JD, Kim TT, Hauschild BC, and Inscho EW (2001) Calcium signaling pathways utilized by P2X receptors in freshly isolated preglomerular MVSMC. Am J Physiol Renal Physiol 280:F1054-F1061.
40. Zhao X, Inscho EW, Bondlela M, Falck JR, and Imig JD (2001) The CYP450 hydroxylase pathway contributes to P2X receptor-mediated afferent arteriolar vasoconstriction. Am J Physiol Heart Circ Physiol 281:H2089-H2096.